Eyepoint Pharmaceuticals, Inc.
EYPT
Revenue
9.48M
▼-2.21M▼-18.89%
3 Months ChangeAssets
324.25M
▼-5.00M▼-1.52%
3 Months ChangeLiabilities
95.94M
▲16.63M▲20.97%
3 Months ChangeFree Cash Flow
-32.37M
▼-15.05M▼-86.88%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Cost Of Revenue
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Revenue
was reported to be 0.00 on 0000-00-00. Compared to last quarter, this is an increase of 0.00 (0.00%).Similarly the
Cost Of Revenue
was 0.00 on 0000-00-00. This comes down to an increase of 0.00 (0.00%).Revenue
Cost Of Revenue
No Data
Date | Revenue | Cost Of Revenue |
---|---|---|
No Data |
Net Profit/Loss
Net Profit/Loss
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Net Profit/Loss
Baseline
No Data
Date | Net Profit/Loss |
---|---|
No Data |
Assets/Liabilities
Assets
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Liabilities
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Assets
was reported to be 0.00 on 0000-00-00. Compared to last quarter, this is an increase of 0.00 (0.00%).Similarly the
Liabilities
was 0.00 on 0000-00-00. This comes down to an increase of 0.00 (0.00%).Assets
Liabilities
No Data
Date | Assets | Liabilities |
---|---|---|
No Data |
Cash Flows
Operating (Cash Flow)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Investing (Cash Flow)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Financing (Cash Flow)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Free Cash Flow
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Operating (Cash Flow)
was reported to be 0.00 on 0000-00-00. Compared to last quarter, this is an increase of 0.00 (0.00%).Similarly the
Investing (Cash Flow)
was 0.00 on 0000-00-00. This comes down to an increase of 0.00 (0.00%).The
Financing (Cash Flow)
was 0.00 and resulted in an increase of 0.00 (0.00%).Free Cash Flow
was 0.00; an increase of 0.00 (0.00%).Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
No Data
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
No Data |
EPS
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
EPS (Diluted)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
EPS
was reported to be 0.00 on 0000-00-00. Compared to last quarter, this is an increase of 0.00 (0.00%).Similarly the
EPS (Diluted)
was 0.00 on 0000-00-00. This comes down to an increase of 0.00 (0.00%).EPS
EPS (Diluted)
No Data
Date | EPS | EPS (Diluted) |
---|---|---|
No Data |
Outstanding Shares
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Outstanding Shares
No Data
Date | Outstanding Shares |
---|---|
No Data |
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001193125-24-248694
2024-10-28
Form 8-K
ID: 0000950170-24-117568
2024-10-24
Form 8-K
ID: 0000950170-24-116847
2024-09-04
Form 8-K
ID: 0000950170-24-103097
2024-08-08
Form 10-Q
ID: 0000950170-24-093853
2024-08-07
Form 8-K
ID: 0000950170-24-092262
2024-06-26
Form 8-K
ID: 0000950170-24-077636
2024-06-21
Form 8-K
ID: 0000950170-24-075872
2024-05-28
Form 8-K
ID: 0000950170-24-064879
2024-05-09
Form 10-Q
ID: 0000950170-24-056380